3D printing company 3D Systems has just announced 510(k) clearance from the Food and Drug Administration (FDA) for their VSP Orthopaedics solution. This development will further increase solutions offered in their VSP approach for orthopaedics, which has already played a role in the treatment of over 120,000 patients—over the past 25 years.
VSP Orthopaedics will allow surgeons to examine the anatomical structure of patients about to have surgery, relying on a ‘clear 3D visualization’ so they can create a patient-specific surgical plan ahead of time. VSP technology has already been used over the long-term as an example of anatomic modeling leadership.
3D Systems continues to demonstrate the benefits of 3D printing to the world with research and development of a wide range of hardware, software, solutions, and support. While all the classic advantages continue to present themselves from speed in manufacturing—not to mention incredible flexibility in design, making changes, and production—to affordability, customization, and more, what is central to medicine is the ability to make patient-specific models, devices, and solutions.